AGING, 2020 · DOI: · Published: June 9, 2020
Neuropathic pain (NP) is a debilitating clinical condition caused by a lesion or disease of the somatosensory system, leading to spontaneous pain and increased sensitivity. Current treatments are unsatisfactory, highlighting the need to understand its causes. This study investigates the role of Mlxipl, a glucose-responsive transcription factor, in neuropathic pain. The research explores how Mlxipl influences inflammation in the spinal dorsal horn (SDH) following nerve injury, potentially alleviating neuropathic pain. The study reveals that after nerve injury, Mlxipl expression increases in the spinal dorsal horn. This upregulation, driven by the transcription factor cJun, appears to inhibit neuroinflammation, thus providing a protective mechanism against neuropathic pain.
Targeting Mlxipl in the spinal dorsal horn might represent an effective strategy for the treatment of neuropathic pain.
Mlxipl provides a protective mechanism for the development and progression of neuropathic pain by inhibiting neuroinflammation in the SDH.
These findings suggest that Mlxipl might be a potential target for the prevention and treatment of NP.